Related Experiment Video
Updated: Aug 21, 2026

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
Published on: January 7, 2019
Salient variables for treatment research of adolescent alcohol and other substance use disorders
Oscar G Bukstein1, Ken Winters
1Department of Psychiatry, Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. buksteinog@upmc.edu
Aims:
To seek a level of uniformity and consistency in the type of data or variables collected to allow cross-study comparison and ease in meta-analyses of adolescent treatment studies.
Design:
The rationale for adoption of such a core set of variables for adolescent treatment research, the main categories and specific types of variables, methods for collecting these variables, including the use of specific instruments are reviewed and discussed.
Findings:
There is a relatively small number of adolescent treatment outcome studies. Between studies, there are highly variable methodologies, including differences in how outcome or treatment success is measured, differences in ascertainment in substance use, differences in the measurement of non-substance use variables such as social and academic functioning, poor follow-up rates and a lack of comparison groups in many studies.
Conclusions:
Differences in the types and collection of baseline and outcome variables and the need to achieve some level of uniformity across adolescent substance use disorders (SUD) treatment studies suggest that investigators interested in adolescent treatment outcome research should develop a set of 'core variables' that are relatively consistent, or at least comparable, across studies.
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Factors Affecting Drug Response: Overview
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Group Design
CNS Depressants: Alcohol and Nicotine
